Science

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC

Aikaterini Semilietof/LinkedIn

Dec 26, 2024, 15:46

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC

A recent paper by Aikaterini Semilietof, Postdoctoral Scholar at the JITC, was mentioned by Journal for ImmunoTherapy of Cancer on X:

“New JITC article.”

“Preclinical model for evaluating human TCRs against chimeric syngeneic tumors”

Authors: Aikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, Julien Pujol, Alessia D’Esposito, Patrick Reichenbach, Philippe Guillaume, Vincent Zoete, Melita Irving, Olivier Michielin.

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. - JITC

More posts featuring Journal for ImmunoTherapy of Cancer.

Aikaterini Semilietof Alessia D'Esposito cancer Elise Gray-Gaillard Evangelos Stefanidis JITC Journal for ImmunoTherapy of Cancer Julien Pujol Melita Irving Olivier Michielin OncoDaily Oncology Patrick Reichenbach Philippe Guillaume Vincent Zoete

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Best of ASCOGI25